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excretion (P 0.004). Greater decrease in weight was an addi-Predictors of antihypertensive response to a standard dose of
tional statistically significant predictor of SBP but not DBPhydrochlorothiazide for essential hypertension.
response, and older age was a predictor of diastolic but notBackground. Determinants of inter-individual variation in
SBP response. The combined effects of all identified predictorsblood pressure (BP) response to antihypertensive therapy re-
accounted for 38% of inter-individual variation in SBP re-main largely unknown. Although differences in race, age and
sponse (P  0.0001) and 20% of inter-individual variation inmeasures of the renin-angiotensin-aldosterone system (RAAS)
DBP response (P  0.0001).have been associated with variation in blood pressure response
Conclusions. A systematic search reveals numerous pre-to hydrochlorothiazide, whether these characteristics make ad-
dictors of BP response to a standard antihypertensive dose ofditive contributions to predicting response has not been estab-
hydrochlorothiazide. However, because the majority of inter-lished. We conducted a comprehensive search for predictors
individual variation in SBP and DBP responses remains unex-of BP response to a standard dose of hydrochlorothiazide in
plained, there is considerable opportunity for future investiga-a biracial sample to estimate how much inter-individual varia-
tions to improve the ability to predict individual BP responsestion in BP response could be explained by all of the identified
to antihypertensive drug therapy.predictors.
Methods. After withdrawal of antihypertensive medications
for at least four weeks (baseline) and stabilization on a diet
approximating 150 mmol sodium per day, 225 African Ameri- Hypertension affects 43 million Americans, of whomcan and 280 Caucasian subjects with diagnosed essential hyper-
approximately 85% have stage I-II (mild-moderate) es-tension were treated for four weeks with hydrochlorothiazide
sential hypertension. Despite the availability of multiple25 mg per day. At baseline and the end of treatment, subjects
were admitted to the General Clinical Research Center for classes of antihypertensive agents with different mecha-
measurement of activity of the RAAS and other regulators of nisms of action, less than 40% of treated patients achieve
BP. Characteristics measured at study enrollment, at baseline, adequate blood pressure control [1, 2]. It has been sug-and in response to drug treatment were incorporated stepwise
gested that blood pressure (BP) responses to particularinto linear regression models in order to quantify their additive
classes of antihypertensive drugs provide insight intocontributions to predicting BP responses to hydrochlorothia-
zide. the mechanisms responsible for the hypertension [3].
Results. Black race and female gender were both associated Therefore, the question is what clinical characteristics
with significantly greater systolic (SBP) and diastolic (DBP) can be measured to identify those individuals most likelyblood pressure responses to hydrochlorothiazide. Together the
to respond to a given antihypertensive agent.combined effects of race and gender accounted for 11% inter-
Hydrochlorothiazide is one of the preferred drugs forindividual variation in SBP response (P  0.0001) and 4%
of inter-individual variation in DBP response (P  0.0001). treatment of uncomplicated mild-moderate hypertension
Additional statistically significant predictors of greater systolic [1]. Characteristics previously associated with greater
and diastolic responses to hydrochlorothiazide included, short- blood pressure response to hydrochlorothiazide areer duration of diagnosed or treated hypertension (P  0.001),
black race, older age, and lower plasma renin activityhigher baseline BP level (P  0.0001), lower baseline plasma
(PRA) [4]. As with all antihypertensive agents, greaterrenin activity (P  0.05), lower baseline urinary aldosterone
excretion (P  0.002), and greater decrease in urinary sodium baseline BP also predicts greater blood pressure re-
sponse [5]. Whereas black race and older age are associ-
ated with higher BP, lower PRA, increased sodium andKey words: African American, Caucasian, hypertension, blood pres-
sure, renin-angiotensin-aldosterone system. decreased potassium intake [6–8], the additive contribu-
tions of these characteristics to predict the BP responseReceived for publication January 30, 2001
to hydrochlorothiazide remains uncertain. Moreover, BPand in revised form October 1, 2001
Accepted for publication October 8, 2001 response to a diuretic is one measure of “sodium sensitiv-
ity,” which also has been associated with obesity, insulin 2002 by the International Society of Nephrology
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resistance, activation of the sympathetic nervous system, trol; allergy to hydrochlorothiazide; inability to discon-
tinue antihypertensive medications; use of non-steroidaland decreased potassium intake [4, 9, 10]. Finally, be-
cause of under-representation of women in many antihy- anti-inflammatory medications including daily aspirin
325 mg per day; congestive heart failure, liver or renalpertensive drug trials [11, 12], it is uncertain if gender
contributes to the prediction of BP response to hydro- disease (serum creatinine concentration 1.5 mg/dL);
diabetes mellitus (fasting blood glucose level 140 mg/chlorothiazide.
The present study undertook a systematic search for dL) or hypoglycemic medications. Women taking oral
contraceptive medications were disqualified; however,predictors of BP response to hydrochlorothiazide in a
bi-racial sample of community and clinic-based patients those receiving post-menopausal hormone replacement
were allowed.with previously diagnosed essential hypertension. We
systematically considered as potential predictors a com- At enrollment, subjects underwent dietary evaluation
by trained dietitians to determine sodium and potassiumprehensive variety of characteristics measured (1) at
study enrollment, (2) at least four weeks after withdrawal intake. Subjects were counseled to maintain a standard
sodium intake of 2 mmol/kg/day. Dietary sodium andfrom previous antihypertensive drug therapy and stabili-
zation on a standard sodium diet, and (3) after four potassium intake was determined weekly throughout the
study from 24-hour urine collections alternating with 24-weeks of hydrochlorothiazide therapy. In addition to
establishing whether race, age, and measures of the re- hour dietary recall diaries. Individuals who demonstra-
ted a sodium intake outside the range of 1.25 to 2.75nin-angiotensin-aldosterone system (RAAS) make addi-
tive contributions to the prediction of BP response, our mmol/kg/day were contacted and re-counseled with re-
gard to appropriate intake. If subjects had a weightspecific objectives were to identify additional predictors
of response and to estimate how much inter-individual change 2% from entry during the washout phase or
2% from baseline during the treatment phase, caloricvariation in response to hydrochlorothiazide could be
explained by the combined effects of all identified pre- intake was adjusted as necessary.
Subjects had antihypertensive medications discon-dictors.
tinued and were evaluated every other week during the
washout period, which lasted at least four weeks. If blood
METHODS
pressure increased above 180/110 mm Hg or symptoms
Subjects developed due to elevated BP, the subject was with-
drawn, pre-study blood pressure medications were re-African American and Caucasian men and women
between 30 and 59 years of age with essential hyperten- started, and the subject was followed-up by his/her pri-
mary physician. If diastolic BP remained 90 mm Hg,sion were recruited at Emory University in Atlanta,
Georgia and Mayo Clinic in Rochester, Minnesota, re- the washout period was extended up to four more weeks.
If diastolic BP still remained 90 mm Hg, the subjectspectively. The study protocol was reviewed and ap-
proved by the Institutional Review Boards of both insti- was excluded from further participation.
At least four weeks after withdrawal of previous anti-tutions. In Atlanta, African American subjects were
recruited through outpatient medical clinics at Grady hypertensive medications, qualifying subjects were ad-
mitted to the General Clinical Research Center (GCRC)Memorial Hospital, the Hypertension and Renal Dis-
eases Research Center at Emory University, advertise- for overnight evaluation. Subjects provided 24-hour urine
collections on the day of admission for measurement ofments in public media, and mailing lists of registered
voters. In Rochester, non-Hispanic whites were recruited sodium, potassium, aldosterone, norepinephrine, epi-
nephrine, dopamine, and creatinine excretion. After ad-from a list of all residents of Olmsted county with the
diagnosis of essential hypertension who had been seen mission, weight, body mass index, and waist-to-hip ratios
were determined [14]. Subjects were required to retireby a health care provider in the previous three years
prior to recruitment [13]. A letter was sent to potential to bed rest by 10:00 pm. At 4:00 am, subjects arose to
void, returned to bed, and an indwelling intravenousstudy subjects providing information about the study.
Interested candidates who contacted the study centers catheter was placed in the non-dominant arm. Subjects
remained supine until after blood samples were ob-were considered for recruitment. Essential hypertension
was defined as a blood pressure greater than 140/90 tained. At 6:00 am, BP was measured in the dominant
arm. Initial blood samples were drawn without a tourni-mm Hg or a previous diagnosis of essential hypertension
and current prescription antihypertensive medications. quet for determination of plasma catecholamine con-
centrations. Additional blood was drawn to determineAfter giving informed written consent, candidates
were evaluated in similar fashion at both sites. Potential serum sodium and potassium concentrations and angio-
tensin-converting enzyme (ACE) activity, PRA, and al-subjects were considered ineligible for study for the fol-
lowing reasons: diseases causing secondary hypertension; dosterone, insulin, cholesterol, and triglyceride concen-
trations. All samples were collected into pre-chilled3 antihypertensive medications for blood pressure con-
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tubes and placed on ice. Tubes were immediately centri- a Cobas Mira analyzer. Norepinephrine concentrations
were determined radioenzymatically.fuged and separated and frozen at80C until the assays
were performed.
Statistical analysisFollowing the initial blood drawing, subjects arose and
Data were summarized by calculating means and stan-ambulated for 30 minutes. Then, blood pressure was
dard deviations for quantitative variables and percent-remeasured after the subject sat for at least five minutes,
ages for categorical variables. In all analyses, statisticaland additional blood was drawn for determination of
significance was inferred when P  0.05. Contrasts be-seated PRA, aldosterone concentration, and serum ACE
tween race and gender subgroups were based on analysisactivity.
of variance (ANOVA) with Sheffe’s correction for pair-Upon completion of the baseline evaluation, subjects
wise contrasts of differences in mean values (for quanti-were given 25-mg hydrochlorothiazide tablets to be
tative variables) or on chi-square contingency tests oftaken daily and then discharged from the GCRC. They
differences in proportions (for categorical variables).returned at least every other week and collected 24-hour
Systolic and diastolic blood pressure responses to hy-urine specimens after two and four weeks of hydrochlo-
drochlorothiazide were defined as the final value (at therothiazide therapy for determination of sodium, potas-
end of drug therapy) minus the baseline value (at the endsium, creatinine, and aldosterone excretion. Compliance
of the washout period). Analyses considered the re-was assessed by pill counts and adequacy of the 24-hour
sponses to hydrochlorothiazide as continuous variables.urine collections was assessed by creatinine excretion
The large number of potential predictor variables andper kg body weight. At the two-week GCRC visit, blood
the co-linearity among these variables dictated that apressure was measured and blood was drawn with sub-
multi-stage analysis strategy be employed. Three classesjects in the seated position for determination of serum
of potential predictor variables were considered: (1)potassium and plasma renin activity and aldosterone
characteristics measured at the enrollment visit (screen-concentrations. After four weeks of therapy, subjects
ing), (2) those measured at the end of the washout periodreturned for overnight admission to the GCRC and un-
(baseline), and (3) those reflecting response to hydro-derwent evaluation in identical fashion to the baseline
chlorothiazide therapy (final  baseline). At the firstvisit.
stage of analysis, each potential predictor trait was assess-If serum potassium was 3.6 mmol/L at the screening
ed in the entire study group, in each race, in each gender,visit, an oral potassium supplement (K-Dur, 20 mmol/
and in each race-gender subgroup. For each quantitativeday; Key Pharmaceuticals, Kenilworth, NJ, USA) was
predictor trait, the significance of its correlation coeffi-prescribed. After two weeks of diuretic therapy, serum
cients with the systolic and diastolic BP responses was
potassium concentration was remeasured; if the value
determined. For categorical traits, the ANOVA was used
was 3.6 mmol/L, an oral potassium supplement (20 to to assess the significance of differences in mean systolic
40 mmol/day) was prescribed. and diastolic BP responses among categories, with ap-
propriate corrections for multiple comparisons, as de-Laboratory analyses
scribed above.
Sodium and potassium were determined by ion selec- Those variables significantly associated with systolic
tive electrode or flame photometry. Plasma renin activity or diastolic BP responses in any of the above analyses
was determined by radioimmunoassay (RIA) of angio- progressed to the next stage of analyses, in which step-
tensin I in the presence of reagents that inhibit angioten- wise multiple linear regression analyses were performed
sin-I converting enzyme and angiotensinases (Dupont to identify combinations of traits that made additive con-
Company, Boston, MA, USA). Plasma and urinary aldo- tributions to the prediction of systolic and diastolic BP
sterone concentrations were determined by RIA (Diag- responses to hydrochlorothiazide. Race and gender were
nostic Products Corporation, Los Angeles, CA, USA). forced into all regression models prior to the stepwise
Serum ACE activity was determined spectrophotometri- addition of other predictors. Separate analyses were
cally. Serum and urine creatinine concentrations and done for predictors measured at study enrollment, for
plasma glucose concentrations were determined by auto- those measured at baseline, and for their changes in
mated spectrophotometric methods implemented on the response to hydrochlorothiazide. Upon completion of
IL Monarch Chemistry System 760 (Instrumentation each stepwise selection process, the percentage of the
Laboratories, Lexington, MA, USA). Insulin concentra- inter-individual variation in BP response explained by
tions were determined using a simultaneous one-step the combined effects of the included predictor variables
immunoenzymatic sandwich assay (Access Ultrasensi- was estimated.
tive Insulin; Sanofi Diagnostics, Chaska, MN, USA). In the final stage of analyses, multiple linear regression
Cholesterol and triglyceride concentrations were deter- was again used to construct a final model by further
stepwise selection from among all three sets of predictormined spectrophotometrically using Roche reagents on
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Table 1. Reasons for withdrawal of subjects from the study Caucasians were taking hormone replacement therapy
(P  0.01).African American Caucasian
The distributions of systolic and diastolic BP responsesMale Female Male Female P value
to hydrochlorothiazide are shown in Figures 1 and 2 for
Total enrolled 120 199 217 250
all subjects. In each gender-race subgroup, the systolicNumber withdrawn 38 56 59 128a,b 0.0003
BP too high 27.7% 16.9% 14.5% 9.9% 0.080 and diastolic BP responses appeared normally distrib-
BP too low 21.5% 25.4% 41.9% 58.3%a,b 0.017 uted (not shown). In response to hydrochlorothiazide,
Abnormal lab 10.8% 6.8% 0.0% 0.8% 0.217
the mean decrease in systolic BP was significantly greaterOther 40.0% 50.9% 43.6% 31.0% 0.297
in African Americans of both genders than in CaucasiansAbbreviations are: BP, blood pressure; lab, laboratory.
a Significant difference between races within genders (P  0.05 for each contrast). Women of both races also
b Significant difference between genders within races demonstrated greater systolic BP and diastolic responses
to hydrochlorothiazide than men (P  0.01 for each
contrast). In multiple regression models, the combined
effects of race and gender accounted for 11% of interin-traits included in the models built at the previous stage.
dividual variation in systolic BP response (P  0.0001)As before, race and gender were forced into the models
and 4% of interindividual variation and DBP responsebefore the stepwise addition of other predictors began.
(P  0.0001).Upon completion of the final selection process, the per-
The time courses of systolic and diastolic BP responsescentage of inter-individual variation in BP response to
to hydrochlorothiazide are shown in Figures 3 and 4.hydrochlorothiazide explained by all of the identified
Maximal decline in BP was achieved at two weeks ofpredictors was estimated.
therapy in Caucasian men and women, whereas four
weeks was required in African American men and
RESULTS women. No such differences in time course were appar-
ent between men and women in either race. The doseTwo hundred and twenty-five African Americans (82
men, 143 women) and 280 Caucasians (158 men and of hydrochlorothiazide per kilogram of body weight was
significantly greater in females of both races than in122 women) completed the study protocol. Caucasian
women were more likely to be discontinued from the pro- men (for African Americans, 0.30  0.07 vs. 0.27  0.06
mg/kg, P  0.005; for Caucasians, 0.31  0.07 vs. 0.26 tocol than Caucasian men or African American women
(52% vs. 27% and 28%, respectively; P  0.05 for both 0.05 mg/kg, P  0.0001), but did not differ significantly
between races in either gender.contrasts), chiefly because diastolic BP did not increase
90 mm Hg during the wash-out period (Table 1).
Predictors of blood pressure responseCharacteristics measured at study enrollment and at
the end of the washout period (baseline) are shown in Characteristics measured at study enrollment. In uni-
variate analyses, enrollment characteristics that were sig-Tables 2 and 3, respectively, for those who completed
the study protocol. Mean values (or percentages) for nificantly associated or correlated with systolic or dia-
stolic BP responses to hydrochlorothiazide includedmost characteristics differed significantly among race-
gender groups. In particular, African Americans of both race, gender, age, level of education, duration of diag-
nosed hypertension, duration of antihypertensive druggenders were characterized by significantly more fre-
quent smoking and greater mean values for duration of treatment, current smoking, potassium supplementation,
alcohol intake, waist-to-hip ratio, body weight, and age athypertension and baseline systolic BP than Caucasians;
whereas Caucasians of both genders were characterized diagnosis of hypertension (Table 2). Of these significant
correlates of response, stepwise multiple linear regres-by significantly more frequent ethanol use, and greater
mean waist-to-hip ratio, serum potassium, plasma triglyc- sion analyses indicated that only black race, female gen-
der, older age, and shorter duration of diagnosed hyper-erides, and urinary potassium excretion than African
Americans. Males of both races were characterized by tension made additive contributions to prediction of
greater systolic BP response, together accounting forsignificantly greater mean waist-to-hip ratio, serum po-
tassium concentration, and urinary excretion of sodium 14% of inter-individual variation (R2  100%) in the
response to hydrochlorothiazide (P  0.0001). For dia-than females, whereas females of both races were charac-
terized by significantly more frequent previous antihy- stolic BP response, the predictors were similar except
duration of antihypertensive drug treatment replacedpertensive drug therapy and potassium supplementation
than males. duration of diagnosed hypertension and together with
race, gender, and age explained 9% of inter-individualAmong women, the frequency of menopause did not
differ significantly between African Americans and Cau- variation in diastolic BP response to hydrochlorothiazide
(P  0.0001).casians (Table 2). However, among the post-menopausal
women, only 37% of African Americans but 67% of Characteristics measured at baseline. Baseline charac-
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Table 2. Subject characteristics measured at study enrollment
African American Caucasian
Characteristic Male Female Male Female P value
Number 82 143 158 122
Age years 48.26.8 47.65.7 48.28.2 50.16.1 0.040
Weight kg 94.219.2 88.720.5 97.817.5b 83.316.4 0.001
BMI 29.85.1 32.97.2b 30.54.9 30.85.4 0.001
Waist:hip 0.920.1b 0.840.1 0.970.1a,b 0.890.1a 0.0001
Age HT Dx 40.29.4 39.18.5 41.810.7 45.86.0a,b 0.0001
HT duration years 8.88.6a 8.17.2a 5.86.9 3.75.0 0.0001
% on Rx 88 96b 90 97b 0.038
Rx duration years 7.07.6 6.96.4a 5.05.9 3.74.6 0.0001
% on K	 26 39a,b 7 16a,b 0.0001
% Smoker 22a 13a 7 4 0.001
% Etoh user 62b 39 83a 82a 0.0001
% College grad 39 31 45b 30 0.035
% Menopause 58 66 0.328
% HRT 37 67a 0.001
Abbreviations are: BMI, body mass index [weight (kg) 
 height squared (m2)]; waist:hip, waist-to-hip ratio; HT, hypertension; Dx, diagnosis; Rx, antihypertensive
drug treatment; K	, potassium supplementation; Etoh, ethanol; HRT, hormone replacement therapy.
a Significant difference between races within genders
b Significant difference between genders within races
Table 3. Subject characteristics measured at end of washout period (baseline)
African American Caucasian
Characteristic Male Female Male Female P value
Number 82 143 158 122
Systolic BP mm Hg 15013a 15315a 14113 14412 0.0001
Diastolic BP mm Hg 985 975a 965b 945 0.0001
Weight kg 9619 8920 9917b 8518 0.0001
Serum Na	 mmol/L 1392.6 1382.7 1392.0 1382.6 0.115
Serum K	 mmol/L 3.80.3 3.70.3 4.10.2a,b 4.00.2a 0.0001
Plasma trig. mg/dL 13868 11649 187108a 17472a 0.0001
Plasma glucose mg/dL 9813 9714a 9611b 9112 0.0001
Plasma insulin lIU/mL 129a 118 96 97 0.007
Plasma Epi pg/mL 1817 1311 2016b 1413 0.0001
Plasma Dopa pg/mL 2429a,b 1611 1211 1215 0.0001
Seated PAC ng/dL 169 2010a,b 168 1510 0.001
Seated PRA ng/mL/h 1.01.0 1.01.1 1.41.2 1.71.3a 0.0001
Serum ACE U/L 147b 125 135 115 0.001
Urine Na	 mmol/24 hr 18871b 15458 17878b 13757 0.0001
Urine K	 mmol/24 hr 5624 4618 7432a,b 5924a 0.0001
Urine Aldo lg/24 hr 8.86.3 9.76.1 10.16.8 9.64.9 0.543
Abbreviations are: BP, blood pressure; Na	, sodium; K	, potassium; Trig, triglycerides; Epi, epinephrine; Dopa, dopamine; PAC, plasma aldosterone concentration;
PRA, plasma renin activity; ACE, angiotensin-converting enzyme; Aldo, aldosterone.
a Significant difference between races within genders
b Significant difference between genders within races
teristics (Table 3) that were significantly correlated with ing for 33% and 13% of inter-individual variation in the
SBP and diastolic BP responses, respectively (P 0.0001systolic or diastolic BP responses to hydrochlorothiazide
included: baseline blood pressure levels; serum concen- for both models).
Characteristics measured in response to hydrochloro-trations of sodium, potassium, and ACE activity; plasma
concentrations of triglycerides, epinephrine, dopamine, thiazide. Response characteristics that were significantly
associated with systolic or diastolic BP responses to hy-and seated PRA; and urinary excretion of sodium, potas-
sium, and aldosterone. Of these significant correlates of drochlorothiazide included changes in weight, plasma
glucose and triglyceride concentrations, and urinary so-response, stepwise multiple regression analyses indicated
that after race and gender only greater baseline BP, dium and aldosterone excretion (not shown). Of these
significant correlates of response, stepwise regressionlower upright PRA, and lower urinary aldosterone excre-
tion made additive contributions to prediction of greater analyses indicated that after race and gender, only
greater weight loss and greater reduction in urinary so-BP responses to hydrochlorothiazide, together account-
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Fig. 3. Time course of systolic blood pressure (SBP) response to fourFig. 1. Frequency distribution histogram of systolic blood pressure
weeks of hydrochlorothiazide, 25 mg per day, in 143 African American(BP) responses to four weeks of hydrochlorothiazide, 25 mg per day,
women (), 82 African American men (), 122 Caucasian women (),in the combined sample of 225 African Americans and 280 Caucasians.
and 158 Caucasian men ().Symbols are: () decreases in BP; () increases in BP. Data are mean
14.4, SD  13.4, N  505.
Fig. 4. Time course of diastolic blood pressure response to four weeks
of hydrochlorothiazide, 25 mg per day, in 143 African American women
Fig. 2. Frequency distribution histogram of diastolic blood pressure (), 82 African American men (), 122 Caucasian women (), and
(DBP) response to four weeks of hydrochlorothiazide, 25 mg per day, 158 Caucasian men ().
in the combined sample of 225 African Americans and 280 Caucasians.
Symbols are: () decreases in BP; () increases in BP. Data are mean
7.8, SD  8.4, N  505.
acteristics that explained the most inter-individual varia-
tion in BP response to hydrochlorothiazide (Table 4).
For the systolic BP response, this analysis indicated thatdium excretion made additive contributions to the pre-
diction of greater SBP response, accounting for 14% of black race, female gender, shorter duration of diagnosed
hypertension, greater baseline systolic BP, lower uprightinter-individual variation in the response to hydrochloro-
thiazide (P  0.0001). Only greater increase in urinary PRA, lower urinary aldosterone excretion, greater weight
loss, and greater reduction in urinary sodium excretionaldosterone excretion and greater decrease in urinary
sodium excretion made additive contributions to the pre- each made additive contributions to the prediction, and
together explained 38% of inter-individual variation indiction of greater DBP response, accounting for 8% of
inter-individual variation in the response to hydrochloro- the systolic BP response to hydrochlorothiazide (P 
0.0001). For diastolic BP response, the analysis indicatedthiazide (P  0.0001).
Final model. Selecting from characteristics included that black race, female gender, older age, shorter dura-
tion of antihypertensive drug treatment, higher baselinein the separate regression models described above, final
stepwise multiple linear regression analyses were per- diastolic BP, lower upright PRA, lower baseline urinary
aldosterone excretion, greater increase in urinary aldo-formed to identify a parsimonious combination of char-
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Table 4. Final model of predictors of blood pressure response to lowering interventions [1]—such as dietary sodium re-
hydrochlorothiazide
striction, weight loss, or exercise—so as to avoid con-
Predictor -coefficient SE P value founding the effects of drug therapy or the associated
Systolic BP predictors. As much as possible, the study protocol was
Race 2.73 1.07 0.011 carried out in an identical fashion in African Americans
Gender 1.89 0.97 0.054
from Atlanta and Caucasians from Rochester to facili-HT duration 0.23 0.07 0.001
Baseline BP 0.44 0.04 0.0001 tate our combined analyses of the data. Nevertheless,
Seated PRA 1.43 0.42 0.001 additional factors may contribute to the observed differ-
U-Aldo 0.37 0.08 0.0001
ences between race-gender subgroups, including differ- Weight 1.18 0.32 0.001
 U-Na	 0.02 0.01 0.004 ences in geography, lifestyle, preceding diet, and activity.
Diastolic BP As surrogates for the combined effects of all such un-
Race 2.54 0.75 0.001
measured factors, “race” and “gender” were included inGender 1.74 0.70 0.014
Age 0.20 0.05 0.0001 all prediction models and interactions with other identi-
Rx duration 0.24 0.06 0.0001 fied predictors were evaluated. Unmeasured differences
Baseline BP 0.40 0.07 0.001
in placebo effects also are possible but unlikely to beSeated PRA 0.60 0.30 0.047
U-Aldo 0.18 0.06 0.002 correlated with the other predictors of BP response. We
 U-Na	 0.013 0.004 0.003 selected subjects with stage I-II essential hypertension
The combined predictors explained 38% of interindividual variation in systolic because these patients represent the majority of hyper-
and 20% of interindividual variation in diastolic blood pressure responses
tensive individuals treated in the United States [12]. Al-(P  0.0001 for both models). Abbreviations are: SE, standard error; BP, blood
pressure; HT, hypertension; PRA, plasma renin activity; U, 24-hour urinary though this cohort was relatively obese (mean BMI was
excretion; Aldo, aldosterone; Na	, sodium; Rx, antihypertensive drug treatment.
greater than 29 kg/m2 in each race-gender subgroup),
measures of body size did not remain in any of the multi-
ple linear regression models as predictors of systolic or
diastolic BP responses to hydrochlorothiazide.sterone excretion, and greater decrease in urinary so-
Similar to other studies, African American and Cauca-dium excretion each made additive contributions to the
sian men had higher baseline systolic and diastolic BPprediction and together accounted for 20% of inter-indi-
than their Caucasian and female counterparts [6, 7, 15].vidual variation in the diastolic BP response to hydro-
We found that African Americans of both genders andchlorothiazide (P  0.0001).
women of both races exhibited greater BP declines in
response to hydrochlorothiazide therapy than their Cau-
DISCUSSION casian and male counterparts, respectively. These find-
This study of African American and Caucasian men ings are consistent with other reports of racial differences
and women with stage I-II essential hypertension de- in BP responses to hydrochlorothiazide [4, 11], but new
scribes a systematic search for clinical characteristics that with regard to greater BP response in hypertensive
predict BP response to a standard dose of hydrochloro- women than men. Among women, neither menopausal
thiazide. The present findings demonstrate that a signifi- status nor hormone replacement therapy was associated
cant percentage of inter-individual variation in systolic with a difference in BP response. Although BP levels,
and diastolic BP responses to hydrochlorothiazide (38% plasma volume, and “sodium-sensitivity” have been re-
and 20%, respectively) can be predicted from character- ported to be greater during the post-ovulatory (luteal)
istics measured at presentation or during the study proto- than the follicular phase of the menstrual cycle [16, 17],
col. Given the complex control of blood pressure and the pre-menopausal women in our study were not uniformly
inherent variability in its measurement, the magnitude of evaluated pre- and post-hydrochlorothiazide treatment
these contributions to the prediction of BP are notable. at the same stage of the menstrual cycle.
It is important to emphasize that the models found to In the final prediction models, age was among the
best predict systolic and diastolic BP responses in this predictors of diastolic BP response to hydrochlorothia-
study were built from measured characteristics chosen zide, even though the age range of subjects (30 to 59
by the investigators for their potential influence on BP, years) did not include elderly individuals. Previous stud-
and that a particular model-building strategy was ap- ies have suggested that older individuals are more salt
plied. Measurement of different characteristics or appli- sensitive [18], demonstrate greater BP response to hy-
cation of a different model-building strategy may have drochlorothiazide [11, 19], and have decreased activation
given different results. However, the present study pro- of the RAAS [4, 20]. Although subjects in those studies
vides benchmark estimates of our current ability to pre- also had higher baseline BP values, which could have
dict individual BP responses to a preferred monotherapy contributed to their greater BP responses to hydrochlo-
for the treatment of essential hypertension. rothiazide, our study suggests that age makes an addi-
tional contribution to the prediction of diastolic BP re-Importantly, this study did not implement other BP-
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Clinic Rochester (MO1-RR00585). This work also was supported bysponse to hydrochlorothiazide in younger hypertensive
U.S. Public Health Service grants RO1-HL53330 from the Division ofindividuals. Research Resources, National Institutes of Health; and funds from
Lower upright renin activity and lower urinary aldo- the Mayo Foundation. An abstract of this work was presented at the
American Society of Nephrology, Annual Meeting, November 6, 1999,sterone excretion made additive contributions to the pre-
in Miami, Florida.diction of greater BP responses to hydrochlorothiazide.
In some but not all previous studies, PRA alone was Reprint requests to Arlene B. Chapman, M.D., Emory University
School of Medicine, WMB Room 318, 1639 Pierce Drive, Atlanta Geor-found to predict BP response to diuretic therapy [21–24].
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